Icosavax Appoints Thomas J. Russo Chief Financial Officer

by on June 10, 2021

Mr. Russo brings more than 25 years of diverse industry experience, including in finance and operations for public biotechnology companies, as a sell-side equity research analyst covering biotechnology, and in operations and vaccine manufacturing for a large pharma company.